Sosei
Warning!
We are expecting a several 10-minute disruptions on this site on Wednesday, 10 March 2010 between 2:00 A.M. – 6:00 P.M. (
We apologize in advance for any inconvenience this may cause.
-
- 2010.02.12
- Summary of Consolidated Financial Results for the 3Q ended 31 December 2009 (abridged English version)
- 2010.01.06
- Update on Phase I Clinical Study of RS(+) Mefloquine for Malaria
- 2009.11.12
- Summary of Consolidated Financial Results for the First Half Year ended 30th September 2009 (abridged English version)
- 2009.11.02
- Sosei Signs Definitive Distribution Agreement with ASKA for Commercialisation of SOH-075 (NorLevo®)
For past news and financial reports, please go to News and Financial Data.
